​

CVS Health (CVS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CVS Stock Forecast

CVS Health (CVS) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $95.00, with a high of $103.00 and a low of $87.00. This represents a 17.52% increase from the last price of $80.84.

$40 $53 $66 $79 $92 $105 High: $103 Avg: $95 Low: $87 Last Closed Price: $80.84

CVS Stock Rating

CVS Health stock's rating consensus is Buy, based on 41 Wall Street analysts. The breakdown includes 2 Strong Buy (4.88%), 32 Buy (78.05%), 7 Hold (17.07%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 41 0 7 32 2 Strong Sell Sell Hold Buy Strong Buy

CVS Price Target Upside V Benchmarks

TypeNameUpside
StockCVS Health17.52%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks14.06%

Price Target Trends

1M3M12M
# Anlaysts91621
Avg Price Target$93.78$93.50$90.48
Last Closing Price$80.84$80.84$80.84
Upside/Downside16.01%15.66%11.92%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 256175--28
Nov, 256165--27
Oct, 257154--26
Sep, 257145--26
Aug, 257137--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 12, 2025Bernstein$87.00$80.847.62%7.62%
Dec 10, 2025Ann HynesMizuho Securities$95.00$79.0520.18%17.52%
Dec 10, 2025Robert W. Baird$92.00$78.2417.59%13.81%
Dec 10, 2025Jessica TassanPiper Sandler$101.00$78.2429.09%24.94%
Dec 10, 2025Morgan Stanley$93.00$78.2418.87%15.04%
Dec 10, 2025Barclays$93.00$78.2418.87%15.04%
Dec 10, 2025Kevin CaliendoUBS$97.00$78.2423.98%19.99%
Dec 10, 2025Truist Financial$100.00$78.2427.81%23.70%
Dec 04, 2025Bernstein$86.00$76.7512.05%6.38%
Oct 30, 2025RBC Capital$93.00$77.5619.91%15.04%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 10, 2025Cantor FitzgeraldOverweightOverweighthold
Dec 10, 2025Piper SandlerOverweightOverweighthold
Dec 10, 2025Morgan StanleyOverweightOverweighthold
Dec 10, 2025BarclaysOverweightOverweighthold
Dec 10, 2025UBSOutperformOutperformhold
Dec 10, 2025Bank of America SecuritiesBuyBuyhold
Dec 04, 2025BernsteinMarket PerformMarket Performhold
Dec 04, 2025RBC CapitalOutperformOutperformhold
Dec 03, 2025UBSBuyBuyhold
Oct 30, 2025RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

$3 $4 $5 $6 $7 $8 $9 $10 $11 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.48$6.00$3.29$6.49$3.66----
Avg Forecast$7.44$8.25$8.63$8.61$5.15$5.87$6.88$8.19$10.15
High Forecast$7.60$8.43$8.95$8.64$5.81$7.03$8.43$8.98$10.69
Low Forecast$7.29$8.09$8.32$8.59$4.65$5.34$5.83$7.49$9.66
Surprise %-26.34%-27.27%-61.88%-24.62%-28.93%----

Revenue Forecast

$250B $300B $350B $400B $450B $500B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$268.71B$292.11B$322.47B$357.78B$372.81B----
Avg Forecast$267.95B$290.59B$315.12B$354.36B$371.88B$385.40B$405.34B$421.93B$443.77B
High Forecast$272.43B$295.45B$324.21B$356.91B$373.69B$401.00B$405.76B$424.16B$461.94B
Low Forecast$263.76B$286.05B$306.42B$351.62B$367.69B$372.45B$404.92B$419.69B$427.19B
Surprise %0.28%0.52%2.33%0.96%0.25%----

Net Income Forecast

$4B $6B $8B $10B $12B $14B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.18B$8.00B$4.31B$8.34B$4.61B----
Avg Forecast$5.39B$6.83B$7.85B$8.34B$6.75B$7.97B$9.20B$10.62B$13.09B
High Forecast$6.47B$8.19B$9.42B$10.01B$7.50B$9.06B$10.88B$11.58B$13.79B
Low Forecast$4.31B$5.46B$6.28B$6.68B$6.00B$6.88B$7.52B$9.66B$12.46B
Surprise %33.22%17.17%-45.10%--31.65%----

CVS Forecast FAQ

Is CVS Health stock a buy?

CVS Health stock has a consensus rating of Buy, based on 41 Wall Street analysts. The rating breakdown includes 2 Strong Buy, 32 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CVS Health is a favorable investment for most analysts.

What is CVS Health's price target?

CVS Health's price target, set by 41 Wall Street analysts, averages $95 over the next 12 months. The price target range spans from $87 at the low end to $103 at the high end, suggesting a potential 17.52% change from the previous closing price of $80.84.

How does CVS Health stock forecast compare to its benchmarks?

CVS Health's stock forecast shows a 17.52% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare plans stocks industry (14.06%).

What is the breakdown of analyst ratings for CVS Health over the past three months?

  • December 2025: 21.43% Strong Buy, 60.71% Buy, 17.86% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 22.22% Strong Buy, 59.26% Buy, 18.52% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 26.92% Strong Buy, 57.69% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.

What is CVS Health’s EPS forecast?

CVS Health's average annual EPS forecast for its fiscal year ending in December 2025 is $5.87, marking a 60.38% increase from the reported $3.66 in 2024. Estimates for the following years are $6.88 in 2026, $8.19 in 2027, and $10.15 in 2028.

What is CVS Health’s revenue forecast?

CVS Health's average annual revenue forecast for its fiscal year ending in December 2025 is $385.4B, reflecting a 3.38% increase from the reported $372.81B in 2024. The forecast for 2026 is $405.34B, followed by $421.93B for 2027, and $443.77B for 2028.

What is CVS Health’s net income forecast?

CVS Health's net income forecast for the fiscal year ending in December 2025 stands at $7.97B, representing an 72.83% increase from the reported $4.61B in 2024. Projections indicate $9.2B in 2026, $10.62B in 2027, and $13.09B in 2028.